Management ChangeJul 2, 2026, 04:38 PM
CorMedix Appoints Elizabeth Hurlburt to COO & CCO; Michael Seckler Departs
AI Summary
CorMedix Inc. announced a change in its executive leadership structure. Elizabeth Hurlburt, previously Chief Operating Officer, has been appointed to the newly created role of Chief Operating and Commercial Officer. In this expanded role, she will oversee all commercial functions, medical affairs, regulatory, and clinical, continuing to report to Chairman & CEO Joseph Todisco. Concurrently, Michael Seckler has departed from the company.
Key Highlights
- Elizabeth Hurlburt appointed Chief Operating and Commercial Officer.
- Ms. Hurlburt's new role includes oversight of commercial functions, medical affairs, regulatory, and clinical.
- She will continue to report to Chairman & CEO Joseph Todisco.
- Michael Seckler has left CorMedix Inc.
Price Impact
More from CRMD